TORONTO--(BUSINESS WIRE)--ADA Medical Ltd. is pleased to announce its collaboration with Ephoran Multi-Imaging Solutions srl. Building on Ephoran’s technology, ADA Medical is expanding into the pre-clinical research space. ADA Medical can now provide research and quality assured based pre-clinical contract services focused on inflammatory, oncology and cardiovascular diseases.
This new molecular imaging CRO service based near Turin in Bioindustry Park Silvano Fumero, Italy, will conduct pre-clinical drug development modeling and assessments using cutting edge technology. ADA Medical’s existing project management, pharmacodynamics, pharmacokinetics, biostatistics, data management and regulatory/quality assurance capabilities will bring needed GLP, pre-clinical management and quality oversight to create the discipline needed for drug research and support of drug research submissions.
“Ephoran’s molecular imaging expertise will bring a much needed new technology to the market to assist drug and biotech companies in expediting cost effective development of new compounds to clinical trials.” commented Renzo DiCarlo, CEO of ADA Medical.
Ephoran is a reference centre for a number of imaging technologies. This expansion into drug development applications fills a void in the pre-clinical drug imaging sector, namely new product verification prior to filling an Investigational New Drug Application (INDA). “We are excited to see our technology be a part of ADA Medical’s medical research family. Imaging technology provides significant biological data that will be used to verify the efficacy of a drug compound and make the drug development process much more effective and quicker” said Vito Lorusso, Vice-President, Ephoran.
For additional information please contact Mr. Daniel Beaulieu, Director, Business Development at email@example.com.
About ADA Medical Ltd.
ADA Medical Ltd. is a Research Partnership Group of research professionals dedicated to the successful implementation and completion of clinical research projects for the pharmaceutical, biotechnology and medical device industries. We specialize in trial management and support for hospital based as well as outpatient Phase IIb through Phase IV clinical trials. Our sites are all located in Canada and each participates in multiple clinical trial projects in multiple therapeutic areas.
About Ephoran Multi-Imaging Solutions srl.
Ephoran Multi-Imaging Solutions is a Contract Research Organization providing imaging expertise and knowledge to study, develop and promote the application of imaging technologies in preclinical drug research and development. Ephoran provides the opportunity to apply a translational pharmacological approach in drug R&D, evaluating in animal models a molecular-based proof of biological activity and mechanism of action, and translating it into the clinical setting. All the Techniques extensively employed in the clinical setting (e.g. PET, CT, SPECT, MRI, US and in Optical Imaging, both visible light and Near Infra Red) are available. It fosters the development of diagnostic tools, reagents and methodologies for experimental imaging and makes your drug development faster and more cost effective. Ephoran has, since its foundation in late 2008, built a relevant network of customers and scientific partners, both in Italy and abroad and has also built long term agreements with the Turin University.